Health Condition 1: J45- Asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children between the age group of 8 to 16 years. Patients of mild to moderate severity of Bronchial Asthma. Only stable cases of Bronchial Asthma (as per WHO GINA guideline) for at least 6 weeks prior to study. Parents/guardians of the children willing to participate in the research trial.
Exclusion criteria
Exclusion criteria: Children aged below 8 and above 16 years. Patients having Status asthmaticus condition, presenting systemic illness like Pneumonia, Pleural Effusion, Pulmonary T.B.,etc.,and patient who is suffering from any congenital or hereditary illness. Patients with PEFR less than 60%. Patients on prolonged (more than 6 weeks) medication with corticosteroids, bronchodilators, etc. Parents or guardians of the children not willing to participate in the research trial. Any other condition which the principal investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Drakshadyavaleha and Devadaru Syrup in the management of Tamaka Shwasa. To compare the efficacy of Drakshadyavaleha and Devadaru Syrup with Syrup Levosalbutamol in the management of Tamaka Shwasa. Timepoint: 3 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To establish a safe & cost-effective medicine for the treatment of Tamaka Shwasa. To evaluate the safety of both the drugs in children. Timepoint: 3 weeks | — |
Countries
India
Contacts
RGGPG Ayurvedic college and Hospital, Paprola.